ClinicalTrials.Veeva

Menu

Early Detection of Fabry Disease

Takeda logo

Takeda

Status

Active, not recruiting

Conditions

Fabry Disease

Treatments

Other: No intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT05106764
FLAGGING FD-1 (Other Identifier)
TAK-675-4011-1

Details and patient eligibility

About

The main aim of this study is early detection of FD using real-world data for the development of advanced natural language processing methods and to develop a predictive algorithm and to measure the performance of the algorithm in identifying participants with FD.

This study is about using data from hospital Electronic Health Record database from the last 10 years to describe the ranking of participants with FD using multilevel likelihood ratios and to validate the algorithm using positive controls. No investigational medicinal product or device will be tested in this study. Hospital electronic health record data will be analyzed for a period of up to 6 months.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  • In-patient or out-patient datasets of the participating hospital in the last 10 years
  • Participants at any age Positive controls: a subset of all participant hospital records that includes the participants with confirmed FD.

Trial design

50 participants in 1 patient group

Retrospective Database Analysis
Description:
Data from patient's hospital records of the last 10 years will be collected/extracted retrospectively using epidemiological methods to test the forecasting power of the algorithm.
Treatment:
Other: No intervention

Trial contacts and locations

3

Loading...

Central trial contact

Takeda Contact

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems